INOLAWYER-OS
  • INOLAWYER Advice
  • INOLAWYER Home
  • INOLAWYER Software
  • Products
  • Pricing
  • News
  • Downloads
  • EN DE
  • EN DE
BOOK A DEMO

Urbach Law advises Fairmed Healthcare and its majority shareholder Strides Pharma on a €10 Million Debt Facility

Fairmed Healthcare AG, Swiss generics company based in Zug, raises senior secured loan from Duke Royalty Limited

By Simon Urbach, Zurich

Jul 02 2021

<p>On July 1, 2021, <a href="https://www.fair-med.com/" target="">Fairmed Healthcare AG</a> announced that it has raised €10 million in senior secured financing from <a href="https://www.dukeroyalty.com" target="">Duke Royalty Limited</a>. Fairmed was founded in 2012 and is based in Zug, Switzerland. The company offers high-quality generic prescription medicines, over-the-counter medicines, dermocosmetics and nutritional supplements in various EU countries. Fairmed is majority owned by Strides Pharma Global Pte Ltd, which in turn is a wholly owned subsidiary of <a href="https://www.strides.com" target="">Strides Pharma Science Limited</a>, a publicly traded corporation.&nbsp;Duke Royalty is listed on AIM and is a provider of alternative capital solutions to a diversified range of businesses in Europe and world-wide.</p><p>Urbach Law acted as transaction counsel for Fairmed Healthcare AG and Strides Pharma Global Pte Ltd. The Urbach Law team was led by partner Simon Urbach and included associates Amelie Hoffmann and Rezeda Maritz.</p><p>Further information on the background of the financing is available at the following link:<br></p><p>​<a href="https://www.londonstockexchange.com/news-article/DUKE/new-royalty-agreement-with-fairmed-healthcare-ag/15040569" target="">London Stock Exchange</a>​<br></p>
Call


Contact us


Teammates

Simon Urbach

Urbach Law

Stavros Koutalas

Koutalas Law

Amelie Hoffmann

Urbach Law

Rezeda Maritz

Urbach Law

Panayiotis Korakovounis

Koutalas Law


Relevant News

Was passiert mit meinem Vermögen nach meinem Tod? Welche Gestaltungsmöglichkeiten habe ich?

Was passiert mit meinem Vermögen nach meinem Tod? Welche Gestaltungsmöglichkeiten habe ich?

Oct 19 2022
Neues Erbrecht ab 2023: Was sich ändert

Neues Erbrecht ab 2023: Was sich ändert

Oct 06 2022
Urbach Law advises Fairmed Healthcare and its majority shareholder Strides Pharma on a €10 Million Debt Facility

Urbach Law advises Fairmed Healthcare and its majority shareholder Strides Pharma on a €10 Million Debt Facility

Jul 02 2021
Auswirkungen des «Brexit» auf die Fragen der Zuständigkeit und der Anerkennung und Vollstreckung von Urteilen

Auswirkungen des «Brexit» auf die Fragen der Zuständigkeit und der Anerkennung und Vollstreckung von Urteilen

Jun 15 2021
 Verzicht auf die amtliche Beglaubigung von Unterschriften bei der Prüfung von Vollmachten

Verzicht auf die amtliche Beglaubigung von Unterschriften bei der Prüfung von Vollmachten

Jan 16 2021
Vision Group AG acquires Urbach Optik AG: Urbach Law advises Urbach Optik AG and majority shareholders

Vision Group AG acquires Urbach Optik AG: Urbach Law advises Urbach Optik AG and majority shareholders

Jan 05 2021
Caution: SECO checks the legality of short-time work compensation

Caution: SECO checks the legality of short-time work compensation

Sep 18 2020
Die Tücken des Google Bewertungsportals

Die Tücken des Google Bewertungsportals

Aug 21 2020

Quick Links

Team

Pricing

Company News

Downloads

Careers

Contact

Policies

Cookie Policy

Terms of Use

Privacy Policy

INOLAWYER Software

Team

Careers

Cookie Policy

Terms of Use

Privacy Policy

Contact

INOLAWYER Software

+41 44 307 70 00

sales@inolawyer.com

INOLAWYER AG

Stockerstrasse 42

CH-8002 Zurich

Switzerland

P.O. Box, CH-8027 Zurich

Register for newsletters & updates

Follow Us:

© 2022 INOLAWYER AG. All Rights Reserved.

Cookie Policy

Terms of Use

Privacy Policy

Cookie Settings